Stockreport

FDA Fast Track for Eczema Therapy Could Be a Game Changer for Nektar Therapeutics (NKTR) [Yahoo! Finance]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF This regulatory milestone could accelerate the therapy's path to market for eczema and reflects growing recognition of the candidate's clinical potential. We'll explo [Read more]